2013 Fiscal Year Final Research Report
New therapy for malignant salivary gland tumor by targeting the hormone receptor
| Project/Area Number |
23592965
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Surgical dentistry
|
|---|
| Research Institution | Kyushu University (2013)
Ehime University (2011-2012) |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2011 – 2013
|
| Keywords | 唾液腺腫瘍 / ホルモンレセプター |
|---|
| Research Abstract |
Progesterone (Pg) is intimately involved in the development of the mammary gland. Further, it is believed that Pg plays a role in breast cancer progression. However, little is known regarding its role in SGTs. In this study, we used ACCM, a human adenoid cystic carcinoma cell line established from the salivary gland, in order to clarify the role of the progesterone receptor (PR) on cell proliferation. No effect of Pg on cell proliferation was observed in the PR-deficient aggressive ACCM cells. However, after introducing PR into the ACCM cells, Pg markedly inhibited the proliferative activity of the cells. This inhibitory effect on cell proliferation was accompanied by p21 upregulation and Id1, c-myc downregulation. Moreover, Pg-treated PR transfectants showed significant morphological change. Our results suggested that PR reintroduction therapy might be a viable method of inhibiting human SGT progression.
|
Research Products
(3 results)
